Polarization of a type 1 anti-tumor immune response in the context of a strong tumor antigen results in the regression of the mammary adenocarcinoma, 4T1
Polarization of a type 1 anti-tumor immune response in the context of a strong tumor antigen results in the regression of the mammary adenocarcinoma, 4T1